Data as of Q4 2025 (Dec 31, 2025)

NETEASE, INC.

(NTES)

Financial Statements · SEC EDGAR XBRL

Revenue
$16.11B
+11.6%
EPS
$1.50
+19.0%
Gross Margin
64.3%
Op. Income
$5.12B
+26.4%
FCF
$7.10B
+35.0%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Gross Profit
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$16.11B
$14.43B
$14.57B
$13.99B
$13.75B
$16.11B
$14.43B
$14.57B
$13.99B
$13.75B
$10.35B
$9.02B
$8.88B
$7.65B
$7.37B
$2.53B
$2.40B
$2.32B
$2.18B
$2.21B
$5.23B
$4.96B
$4.98B
$4.80B
$4.79B
$5.12B
$4.05B
$3.90B
$2.85B
$2.58B
$155.4M
$82.5M
$148.4M
$122.8M
$111.5M
$5.84B
$4.89B
$4.80B
$3.52B
$3.31B
$862.7M
$748.2M
$661.9M
$729.5M
$647.8M
$1.52
$1.27
$1.29
$0.90
$0.80
$1.50
$1.26
$1.27
$0.89
$0.79
3.22B
3.23B
3.25B
3.30B
3.37B